First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 781 000 KRW Market Closed
Updated: May 15, 2024

Cash Flow Statement

Cash Flow Statement
Samsung Biologics Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: KRW
Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Operating Cash Flow
Net Income
1 913 289
1 869 184
(176 823)
(184 194)
(156 258)
(143 852)
(96 972)
(110 558)
(107 990)
(103 273)
224 109
232 318
238 438
309 563
202 904
278 007
343 437
355 375
240 975
265 298
334 801
410 494
393 589
479 556
510 074
507 465
798 056
792 869
825 714
936 917
857 691
Depreciation & Amortization
52 630
68 195
60 149
63 758
64 790
66 453
69 926
74 038
78 070
81 928
91 450
103 094
115 289
127 864
132 543
134 325
136 635
139 520
143 175
148 356
152 715
156 969
161 789
164 906
214 137
257 989
308 264
366 660
386 413
440 285
489 782
Other Non-Cash Items
(2 062 552)
(2 025 592)
151 342
175 975
146 810
163 097
161 539
183 360
214 290
203 644
(142 995)
(171 502)
(216 268)
(274 263)
(85 583)
(79 166)
(46 649)
(38 339)
66 158
50 824
70 880
126 871
187 832
212 060
221 070
408 284
289 411
322 723
309 899
164 264
312 968
Cash Taxes Paid
(274)
(274)
(63)
0
(150)
(150)
(150)
31
456
748
1 131
0
40 260
42 145
42 105
47 360
15 466
26 041
38 429
42 241
49 217
54 860
42 369
81 416
135 197
178 692
188 473
246 675
294 899
274 326
319 321
Cash Interest Paid
14 794
21 200
24 362
24 466
22 297
19 463
17 036
15 465
16 574
20 053
23 359
26 366
28 118
27 602
26 345
23 756
20 832
17 902
15 630
15 287
15 485
15 008
18 594
21 294
20 274
27 573
33 940
41 068
52 809
59 365
63 486
Change in Working Capital
(168 940)
(196 944)
(97 330)
(110 986)
(50 488)
(54 343)
15 323
(21 429)
(75 826)
(125 915)
(205 582)
(157 360)
(212 335)
(224 694)
(239 711)
(231 785)
(150 825)
(7 778)
(248 218)
(456 064)
(489 438)
(496 838)
(288 614)
(116 478)
(370 769)
(415 375)
(442 684)
(425 428)
(224 239)
(398 943)
5 787
Cash from Operating Activities
(265 573)
N/A
(285 158)
-7%
(62 661)
+78%
(55 446)
+12%
4 855
N/A
31 356
+546%
149 816
+378%
125 412
-16%
108 544
-13%
56 383
-48%
(33 017)
N/A
6 551
N/A
(74 877)
N/A
(61 528)
+18%
10 154
N/A
101 382
+898%
282 600
+179%
448 780
+59%
202 090
-55%
8 415
-96%
68 957
+719%
197 495
+186%
454 596
+130%
740 043
+63%
574 512
-22%
758 364
+32%
953 048
+26%
1 056 823
+11%
1 297 787
+23%
1 142 523
-12%
1 666 229
+46%
Investing Cash Flow
Capital Expenditures
(161 117)
(201 981)
(168 171)
(219 291)
(351 275)
(442 387)
(504 802)
(536 991)
(453 587)
(368 915)
(284 459)
(242 637)
(195 180)
(177 658)
(181 196)
(119 764)
(118 098)
(120 697)
(148 566)
(212 740)
(317 901)
(384 313)
(421 152)
(641 798)
(693 806)
(877 323)
(1 009 226)
(1 184 660)
(1 174 496)
(1 051 577)
(1 105 325)
Other Items
(53 693)
(53 693)
(1 204 653)
(914 653)
(417 481)
(417 495)
769 987
469 275
(400 714)
(370 700)
(346 931)
(237 458)
274 585
424 607
520 838
282 077
140 054
(170 015)
(270 120)
99 880
269 886
(302 442)
(512 337)
(319 108)
(3 603 376)
(2 707 516)
(2 097 252)
(1 652 395)
516 438
110 022
(460 981)
Cash from Investing Activities
(214 809)
N/A
(255 673)
-19%
(1 372 824)
-437%
(1 133 944)
+17%
(768 756)
+32%
(859 882)
-12%
265 185
N/A
(67 716)
N/A
(854 301)
-1 162%
(739 616)
+13%
(631 390)
+15%
(480 095)
+24%
79 405
N/A
246 950
+211%
339 642
+38%
162 313
-52%
21 955
-86%
(290 712)
N/A
(418 686)
-44%
(112 860)
+73%
(48 015)
+57%
(686 755)
-1 330%
(933 489)
-36%
(960 907)
-3%
(4 297 182)
-347%
(3 584 838)
+17%
(3 106 477)
+13%
(2 837 056)
+9%
(658 059)
+77%
(941 555)
-43%
(1 566 305)
-66%
Financing Cash Flow
Net Issuance of Common Stock
0
0
1 484 261
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3 188 321
3 200 751
3 200 751
3 200 871
12 550
200
200
Net Issuance of Debt
354 931
404 855
147 030
(247 414)
(358 176)
(378 100)
(287 176)
112 874
422 615
386 365
323 941
184 938
(81 820)
(184 016)
(239 806)
(269 976)
(243 778)
(118 862)
122 560
125 933
(7 005)
567 707
496 622
539 695
662 149
(143 257)
(188 241)
(272 148)
(327 452)
(292 673)
(635 250)
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(12 430)
(12 430)
0
0
0
0
Cash from Financing Activities
488 615
N/A
538 539
+10%
1 631 292
+203%
1 236 848
-24%
1 126 086
-9%
1 106 162
-2%
(287 176)
N/A
112 874
N/A
422 615
+274%
386 365
-9%
323 941
-16%
184 938
-43%
(81 820)
N/A
(184 016)
-125%
(239 806)
-30%
(269 976)
-13%
(243 778)
+10%
(118 862)
+51%
122 560
N/A
125 933
+3%
(7 005)
N/A
567 707
N/A
496 622
-13%
539 695
+9%
3 850 469
+613%
3 045 064
-21%
3 000 080
-1%
2 916 293
-3%
(327 332)
N/A
(292 473)
+11%
(635 050)
-117%
Change in Cash
Effect of Foreign Exchange Rates
275
(310)
22
0
0
0
(76)
0
0
0
0
0
0
0
(2 511)
(2 199)
(2 418)
(2 684)
(2 215)
(1 811)
(1 445)
2 084
831
2 594
3 751
19 291
(3 242)
4 263
9 416
(4 743)
12 245
Net Change in Cash
8 508
N/A
(2 602)
N/A
195 829
N/A
47 458
-76%
362 185
+663%
277 636
-23%
127 749
-54%
170 570
+34%
(323 142)
N/A
(296 868)
+8%
(340 466)
-15%
(288 606)
+15%
(77 292)
+73%
1 406
N/A
107 479
+7 544%
(8 480)
N/A
58 359
N/A
36 522
-37%
(96 251)
N/A
19 677
N/A
12 492
-37%
80 530
+545%
18 560
-77%
321 426
+1 632%
131 551
-59%
237 880
+81%
843 409
+255%
1 140 323
+35%
321 813
-72%
(96 248)
N/A
(522 882)
-443%
Free Cash Flow
Free Cash Flow
(426 690)
N/A
(487 139)
-14%
(230 832)
+53%
(274 737)
-19%
(346 420)
-26%
(411 031)
-19%
(354 986)
+14%
(411 579)
-16%
(345 043)
+16%
(312 532)
+9%
(317 476)
-2%
(236 086)
+26%
(270 057)
-14%
(239 186)
+11%
(171 042)
+28%
(18 382)
+89%
164 502
N/A
328 083
+99%
53 524
-84%
(204 325)
N/A
(248 944)
-22%
(186 818)
+25%
33 444
N/A
98 245
+194%
(119 293)
N/A
(118 959)
+0%
(56 178)
+53%
(127 837)
-128%
123 290
N/A
90 946
-26%
560 904
+517%

See Also

Discover More